Previous studies have indicated that SMARCA4 mutations do occur in GBM but infrequently, with evaluation of the online cBioPortal database (https://www.cbioportal.org/) revealing that SMARAC4 mutations are observed in less than 2% of GBM cases [20, 64]. Here, SMARCA4 is linked to glioblastoma.